679 Characterization of tumor specific CD8+ T cell responses in patients with recurrent/metastatic HPV16-positive head and neck cancer receiving HB-200 monotherapy as second or later line treatment in a phase 1 study

Journal for ImmunoTherapy of Cancer(2023)

引用 0|浏览8
暂无评分
关键词
neck cancer,specific cd8+,head
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要